Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Bokang Cui

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0334-9761; OpenAlex author ID A5085988243. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 4 papers · 2024: none · 2025: 1 paper

Papers 7

  1. Elevated SAMD3 expression in T cells predicts improved survival in pancreatic ductal adenocarcinoma patients. Last author DOI 10.1007/s00262-025-03948-x↗
  2. Analysis of Risk Factors for Distant Metastasis of Pancreatic Ductal Adenocarcinoma without Regional Lymph Node Metastasis and a Nomogram Prediction Model for … Co-author DOI 10.1155/2023/2916974↗
  3. IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer. Co-author DOI 10.1186/s12967-023-04800-5↗
  4. Adjuvant chemotherapy in pancreatic cancer at different AJCC stages: a propensity score matching analysis. Co-author DOI 10.1186/s40001-023-01572-y↗
  5. Prognostic nutritional index as a potential prognostic marker for pancreatic cancer after distal pancreatectomy: A single-center, retrospective cohort study Last author DOI 10.21203/rs.3.rs-2415552/v1↗
  6. [Combining intraoperative ultrasound-guided irreversible electroporation with chemotherapy for treating locally advanced pancreatic cancer: a clinical report o… Co-author DOI 10.3760/cma.j.cn112139-20200331-00270↗
  7. Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity sco… Co-author DOI 10.1186/s12885-019-5607-3↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Enliang Zhou · 3 shared papers, 2023–2025 · strength 0.74
  2. Xiaojun Lin · 3 shared papers, 2019–2023 · strength 0.51
  3. Xiaohui Li · 2 shared papers, 2023 · strength 0.47
  4. Lingyi Fu · 1 shared paper, 2025 · strength 0.27
  5. Shuo Li · 1 shared paper, 2025 · strength 0.27
  6. Xiang‐Ming Lao · 2 shared papers, 2019–2020 · strength 0.23
  7. Chaobin He · 2 shared papers, 2019–2020 · strength 0.23
  8. Xiaohui Li · 1 shared paper, 2023 · strength 0.20
  9. Xujia Li · 1 shared paper, 2023 · strength 0.20
  10. Jinsheng Huang · 1 shared paper, 2023 · strength 0.20
  11. Guifang Guo · 1 shared paper, 2023 · strength 0.20
  12. S P Li · 1 shared paper, 2020 · strength 0.13
  13. Xiaofeng Lin · 1 shared paper, 2020 · strength 0.13
  14. Shengping Li · 1 shared paper, 2019 · strength 0.10
  15. Shuxin Sun · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.